Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

invasion

  • You have access
    PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
    Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
    Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294
  • You have access
    Enterolactone modulates the ERK/NF-κB/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB-231 to revert the TGF-β-induced epithelial–mesenchymal transition
    Aniket V. Mali, Asavari A. Joshi, Mahabaleshwar V. Hegde and Shivajirao S. Kadam
    Cancer Biology & Medicine May 2018, 15 (2) 137-163; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0012
  • You have access
    GNAI1 Suppresses Tumor Cell Migration and Invasion and is Post-Transcriptionally Regulated by Mir-320a/c/d in Hepatocellular Carcinoma
    Jian Yao, Lin-hui Liang, Yu Zhang, Jie Ding, Qi Tian, Jin-jun Li and Xiang-huo He
    Cancer Biology & Medicine December 2012, 9 (4) 234-241; DOI: https://doi.org/10.7497/j.issn.2095-3941.2012.04.003
  • You have access
    Suppression of Human Liver Cancer Cell Migration and Invasion via the GABAA Receptor
    Zhi-ao Chen, Mei-yan Bao, Yong-fen Xu, Ruo-peng Zha, Hai-bing Shi, Tao-yang Chen and Xiang-huo He
    Cancer Biology & Medicine June 2012, 9 (2) 90-98; DOI: https://doi.org/10.3969/j.issn.2095-3941.2012.02.002
  • You have access
    Clinical Analysis of 13 Cases with Burkitt Lymphoma or Burkitt-like Lymphoma
    Ning-jing LIN, Wen ZHENG, Yun-tao ZHANG, Xiao-pei WANG, Yu-qin SONG, Yan XIE, Mei-feng TU, Ling-yan PING and Jun ZHU
    Clinical Oncology and Cancer Research April 2010, 7 (2) 110-115; DOI: https://doi.org/10.1007/s11805-010-0504-1
  • You have access
    The Biological Effect of Hepsin on the Proliferation and Invasion of PC-3 Prostate Cancer Cells
    Yong Xu, Zhiqiang Fan, Jantao Sun, Ranlu Liu, Weiming Zhao, Chunyu Wang and Zhang Ju
    Chinese Journal of Clinical Oncology August 2006, 3 (4) 288-291;

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire